{"id":"W2601720937","doi":"10.1200/jco.2012.30.15_suppl.4118","title":"Updated results from a phase III trial of sunitinib versus placebo in patients with progressive, unresectable, well-differentiated pancreatic neuroendocrine tumor (NET).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; McGill University Health Centre","funders":"","keywords":"Medicine; Clinical endpoint; Sunitinib; Internal medicine; Placebo; Neuroendocrine tumors; Progression-free survival; Randomized controlled trial; Dosing; Gastroenterology; Overall survival; Urology; Oncology; Surgery; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005450443,0.0008464581,0.002709848,0.0003971987,0.0003445369,0.0008892099,0.0007717464,0.001145855,0.004107995],"category_scores_gemma":[0.005567686,0.0004748683,0.002094192,0.0004844859,0.0003972945,0.0008016679,0.0003707004,0.001637155,0.0006195277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008060667,"about_ca_system_score_gemma":0.001040371,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008536169,"about_ca_topic_score_gemma":0.002662682,"domain_scores_codex":[0.9981083,0.001226336,0.0001803927,0.0001640814,0.0002048444,0.0001160308],"domain_scores_gemma":[0.9965287,0.001179283,0.001319521,0.0002570001,0.0003050392,0.0004105583],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9008404,0.002299854,0.003201103,0.002625511,0.004661117,0.0001059974,0.0001322288,0.0008181818,0.005088632,0.0001169163,0.005243964,0.07486603],"study_design_scores_gemma":[0.8825012,0.08115466,0.01918551,0.0002602407,0.008012877,0.0002524799,0.00003659584,0.0004899038,0.001509037,0.0002405633,0.006321906,0.00003518192],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9001977,0.06190397,0.002257814,0.002641253,0.0009504002,0.00814799,0.0159553,0.0002536763,0.007691937],"genre_scores_gemma":[0.9641266,0.01090379,0.003075758,0.001935888,0.0006266324,0.004471002,0.01164391,0.00005084923,0.003165603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005450443,"threshold_uncertainty_score":0.02882504,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0853334689336662,"score_gpt":0.4497897587862639,"score_spread":0.3644562898525977,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}